2m 2m 2m 2m 2m 2m 2m
THERAPEUTICSMD (TXMD)
NASDAQ
$2.05+$0.04 (+2.25%)
Price as of Jun 23, 2026 6:22 PM EDT- $23.1MMarket Cap
- 69.49%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
THERAPEUTICSMD (TXMD)
$2.05+$0.04 (+2.25%)
TXMD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.00 | ||
Change | $0.00 (0.00%) | ||
Open | $2.01 | ||
High | $2.09 | ||
Low | $1.99 | ||
Previous Close | $2.00 | ||
Volume | 18,916 | ||
30-Day Average Volume | 68,637 | ||
1-Week Change | -12.66% | ||
1-Month Change | -5.66% | ||
1-Year Change | 69.49% | ||
3-Year Change | -50.74% | ||
5-Year Change | -96.67% | ||
Fundamentals | |||
Shares Outstanding | 11.6M | ||
Total Assets | $37.6M | ||
Market Cap | $23.1M | ||
Enterprise Value | $14.7M | ||
Period: QTR TTM FY | |||
Revenue | $724,000.00 | ||
Net Income | $95,000.00 | ||
Free Cash Flow | $936,000.00 | ||
EBIT | $95,000.00 | ||
EBITDA | $189,000.00 | ||
Net Working Capital | $10.4M | ||
EPS | $0.01 | ||
Enterprise Value/EBITDA | 78 | ||
Enterprise Value/Revenue | 20 | ||
P/B | 1 | ||
P/E | 200 | ||
PEG | 2 | ||
Price/Free Cash Flow | 25 | ||
Price/Operating Cash Flow | 25 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 05/09/2022 | ||
Earnings & Revenue